24 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
and Management Initiative ... (PAMI) - Neuropathic ... Pain Medications ... #Pain #Pharmacology ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Pain Assessment ... Management #Pain ... #Pharmacology # ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Procedural Sedation and Analgesia Medications 

#Management #Pain #Pharmacology #PSA
Pain Assessment ... #Management ... #Pain #Pharmacology ... #Doses #Dosing ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... (PAMI) - Muscle ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... (PAMI) - Nerve ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... (PAMI) - Intranasal ... #Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Total dose should ... respiratory tract infection ... anti-IL6 mAb) #AntiIL6 ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... be considered (doses ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Pearls for Treatment of Alcohol Use Disorder

First-line pharmacotherapies for moderate to severe AUD include naltrexone and
include abdominal pain ... respectively) at the doses ... #UseDisorder #Management ... Screening #Addiction #Medications ... #Pharmacology